Nomacopan

DB14991Investigational

Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).

Mechanism: Pharmacologically active on Complement C5
Curator reviewed
Also known as: COVERSIN

Resolves to

Compound

UNII79V7Q9VIWQCAS875125-19-2

Targets

P01031C5

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nomacopan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account